Log in to save to my catalogue

Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prim...

Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prim...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4391c42f70a74cd08f64714ae6211b5f

Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization

About this item

Full title

Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization

Publisher

London: Nature Publishing Group UK

Journal title

npj vaccines, 2025-03, Vol.10 (1), p.43-13, Article 43

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

mRNA vaccine has become a promising technology platform for rabies prevention. This study explores the roles of different structural domains of rabies virus glycoprotein (RABV-G) and heterologous prime-boost strategies for enhanced immune responses and protection. The results suggested that mRNA vaccines encoding full-length RABV-G (RABV-Full) and...

Alternative Titles

Full title

Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4391c42f70a74cd08f64714ae6211b5f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4391c42f70a74cd08f64714ae6211b5f

Other Identifiers

ISSN

2059-0105

E-ISSN

2059-0105

DOI

10.1038/s41541-025-01098-w

How to access this item